Medochemie's decision to expand cooperation with Data3s by implementing eluzzion CRM, a best-in-class platform for customer relationship management and field reporting that works on all major devices and operating systems, in their Czech office came after a successful bid against which several of the leading global providers of CRM to life sciences companies competed.
Speaking from Cyprus, Yiannakis Mouzouris, Medochemie's Exports Manager, expressed his confidence in Data3s, saying, "We are more than confident that Data3s will prove to be a reliable partner for us in the Czech and Slovak Republic, and our expectations from this partnership - which are very high - will be met in full."
Speaking from Prague, Data3s's CEO, Antonín Lukeš, said, "Medochemie is a company focused on creating deep and long-lasting customer relationships that truly benefit patients. We are proud to support that mission by providing Medochemie with tools that enable them to develop and maintain strong, positive relationships within the health care community and bring affordable high-quality medicines to people around the world."
About Medochemie Ltd.
Medochemie Ltd is an international generic pharmaceutical manufacturer headquartered in Cyprus and a member of EGA (European Generic Medicines Association)
# # #
Data3s is one of the fastest growing providers of innovative solutions for customer relationship management (CRM), business intelligence, multi-channel marketing, eLearning, clinical studies, and creative business solutions for life science organizations worldwide. Our high quality products employ the latest technologies to help our customers sell more, faster and achieve better results. Founded in 2006, Data3s is a privately owned company headquartered in Prague, Czech Republic, with full-service partners and representative offices in Warsaw, Bucharest, Paris, Istanbul, Mumbai, Dubai, Jakarta, Boston and Sao Paulo. To learn more about Data3s, please visit http://data3s.com